GlassScriptPhysician profile
Bertha D Flores
NPI 1942032602
$598.99
in general payments reported to CMS, 2019-2025
11 companies · $599 in 2025
The $599 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $117.09 | 2025 | Yeztugo |
| Glaxosmithkline, LLC. | $105.79 | 2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Xeris Pharmaceuticals, INC. | $76.16 | 2025 | Gvoke Hypopen, Recorlev |
| Madrigal Pharmaceuticals | $71.11 | 2025 | Rezdiffra |
| Novo Nordisk INC | $49.59 | 2025 | Rybelsus, Ozempic, Wegovy |
| Edwards Lifesciences Corporation | $43.19 | 2025 | Sapien 3 Ultra Resilia |
| Scilex Pharmaceuticals INC. | $40.12 | 2025 | |
| Lilly USA, LLC | $28.83 | 2025 | Mounjaro |
| Abbvie INC. | $28.57 | 2025 | |
| Braeburn INC. | $23.55 | 2025 | Brixadi |
| Viiv Healthcare Company | $14.99 | 2025 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertha Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.